Clinical Trial Update: A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis [Phase 3]

View source ↗

Summary

Ipsen's long-term Phase 3 trial is evaluating elafibranor in adults with primary biliary cholangitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Elafibranor

Snippet

Sponsor: Ipsen | Conditions: Primary Biliary Cholangitis (PBC) | Phase 3 | Status: RECRUITING